Clinical trials
Phase 2 Urinary Bladder Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2 |
| Hellenic GenitoUrinary Cancer Group | 2 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2 |
| Amgen | 1 |
| Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | 1 |
| Betul Kartal | 1 |
| Biofabri, S.L | 1 |
| Central South University | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 34 |
| Carcinoma, Transitional Cell | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Renal Cell | 2 |
| Neoplasms | 2 |
| Adenocarcinoma, Follicular | 1 |
| Adrenocortical Carcinoma | 1 |
| Anus Neoplasms | 1 |
| Brain Neoplasms | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.